Longevity News
The latest longevity research, curated from leading sources and analyzed through the EDGE Framework.
The latest longevity research, curated from leading sources and analyzed through the EDGE Framework.
Mito Health, a direct-to-consumer diagnostics platform, has administered over one million tests across seven preventive categories including genomic sequencing, microbiome analysis, advanced imaging, and liquid biopsy screening. The expansion reflects growing demand for accessible, transparent-pricing diagnostic services that operate outside traditional insurance infrastructure.
Akkermansia muciniphila, a gut bacterium that declines with age but remains abundant in healthy centenarians, extends healthspan through mechanisms that reinforce intestinal barrier integrity, restore metabolic balance, suppress chronic inflammation, and modulate immune function. Supplementation with this organism and its bioactive derivatives shows clinical efficacy in reversing age-related decline across neurodegenerative, metabolic, musculoskeletal, and vascular domains.
LifespanningRx released the Peptide Explorer, a structured digital questionnaire that maps health goals across ten domains and flags potential peptide therapy candidates for clinician review. The tool screens responses against safety criteria before recommending further evaluation, positioning peptide therapy within a clinician-supervised framework rather than direct-to-consumer access.
A single endoscopic duodenal ablation procedure maintained approximately 84% of GLP-1-induced weight loss at one year in selected patients, compared to 46% in sham-treated controls. This addresses a significant clinical gap: weight regain after GLP-1 discontinuation, which is common and well-documented.
Bifidobacterium pseudocatenulatum and its metabolite 5-aminovaleric acid betaine decline with age and, when restored, reduce inflammatory aging markers and extend healthspan in mice. This identifies a specific microbial-metabolic pathway linking microbiome composition to systemic inflammation and longevity.
Metabolic signatures derived from five epigenetic aging biomarkers show measurable associations with age-related disease, health decline, and modifiable lifestyle factors in a cohort of over 7,000 older adults. BMI, smoking, alcohol consumption, and physical activity emerge as the strongest lifestyle determinants of these metabolic aging signatures, with potential clinical utility for identifying individuals at higher risk of physiological decline.
Metabolic liver disease progresses through reversible stages when detected early, with steatosis and fibrosis capable of regression through intervention on underlying metabolic drivers. Early detection and metabolic optimization offer a critical window to prevent irreversible cirrhosis and preserve hepatic function.
Regenerative aesthetic procedures may elicit stronger tissue responses when the extracellular matrix is nutritionally and metabolically prepared beforehand. ECM priming—supporting fibroblast function through collagen peptides and micronutrient provision—addresses the gap between treatment stimulus and cellular capacity to synthesize organized collagen.
Pemvidutide, a dual glucagon/GLP-1 receptor agonist, has enrolled its first patients in PERFORMA, a Phase 3 trial for metabolic dysfunction-associated steatohepatitis (MASH). The drug targets hepatic lipid clearance directly through glucagon signaling rather than relying solely on appetite suppression, positioning it mechanistically distinct from monotherapy GLP-1 drugs in addressing liver fat accumulation and fibrosis.
Age-related taste loss stems from impaired stem cell regeneration in taste buds, driven by inflammatory macrophage accumulation that releases inhibitory signals blocking taste cell growth. This mechanism connects taste dysfunction to broader age-associated inflammation and suggests specific molecular targets for intervention.
Enveda's ENV-308 mimics Lac-Phe, a hormone released during intense exercise that suppresses appetite. Phase 1 results show exceptional gastrointestinal tolerability and evidence of real metabolic activity, positioning it as a potential tool to sustain weight management benefits after GLP-1 discontinuation.
A longitudinal analysis of community-dwelling older adults demonstrates that adherence to Mediterranean lifestyle patterns—encompassing diet, physical activity, social engagement, and sleep quality—correlates with reduced mortality and improved functional independence. The protective effects persist after adjustment for individual dietary components, indicating that the integrated lifestyle approach produces measurable clinical outcomes beyond any single intervention.